MAL and carcinoma: ROC curve analyses further confirmed the superior performance of the combined CADM1/MAL methylation panel in detecting carcinoma (AUC = 0.912), compared to CADM1 and MAL alone (both AUC = 0.770) and PAX1 (AUC = 0.813).